Alexandru-Crivac, Cristina N.
Umeobika, Christian
Leikoski, Niina
Jokela, Jouni https://orcid.org/0000-0001-5096-3575
Rickaby, Kirstie A.
Grilo, André M.
Sjö, Peter https://orcid.org/0000-0002-6768-0536
Plowright, Alleyn T.
Idress, Mohannad
Siebs, Eike
Nneoyi-Egbe, Ada
Wahlsten, Matti https://orcid.org/0000-0002-4107-1695
Sivonen, Kaarina https://orcid.org/0000-0002-2904-0458
Jaspars, Marcel https://orcid.org/0000-0002-2426-6028
Trembleau, Laurent https://orcid.org/0000-0001-6376-9077
Fewer, David P. https://orcid.org/0000-0003-3978-4845
Houssen, Wael E. https://orcid.org/0000-0001-9653-5111
Funding for this research was provided by:
AstraZeneca
Biotechnology and Biological Sciences Research Council (BB/M013669/1, BB/M028526/1)
RELATED DATA
IDENTIFIERS
COPYRIGHT AND LICENSING
: The Royal Society of Chemistry has an exclusive publication licence for this journal
PEER REVIEW METHOD
: Authors can choose between single-blind and double-blind peer review
PUBLICATION HISTORY
: Received 28 July 2017; Accepted 5 September 2017; Accepted Manuscript published 11 September 2017; Advance Article published 14 September 2017; Version of Record published 26 September 2017